Health Sciences In The Media Dr. Ali Baaj to Build UArizona-Banner Spine Program from Scratch in New Role Nov. 11, 2020 Spine surgeon Ali Baaj, MD, is the inaugural chief of spine surgery at the University of Arizona College of Medicine-Phoenix and Banner-University Medical Center Phoenix. As spine surgery chief, Dr. Baaj will build a new academic spine program at UArizona-Banner. Becker's Spine Review The Swinging Pendulum of PSA Screening Nov. 11, 2020 The debate continues over the practice of mass screening of healthy men with prostate-specific antigen (PSA) blood tests for the early detection of prostate cancer. The article cites Richard Ablin, PhD, of the University of Arizona College of Medicine, who discovered PSA in 1970. He stressed that PSA testing was not intended for use for mass screening but rather to follow men with advanced disease. MedPage Today COVID-19: Vaccines Continue to Progress as More Proof of Long-Lasting Immunity Emerges Nov. 11, 2020 Researchers at the University of Arizona College of Medicine in Tucson have found that people who have had COVID-19 develop long-lasting immunity. Their study appears in the journal Immunity. Medical News Today Moderna’s Personalized Cancer Vaccine Shows Promise Nov. 11, 2020 A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer. PharmaLive Pandemic Shines Light on Complex Coexistence of Modern Times, Traditional Ways on Navajo Nation Nov. 10, 2020 Traditional healers, who once played critical roles in governance and health care in the Navajo Nation, are dwindling in number and influence, experts and community leaders say, even as a deadly coronavirus assaults the tribe. Michelle Kahn-John, a professor of nursing at the University of Arizona and secretary of the Diné Hataalii Association, is quoted. This article was first published by the syndicated Cronkite News service on 11/10/20. Cronkite News Arizona Medical Expert Says There Could Be Challenges in Distributing COVID-19 Vaccine Nov. 10, 2020 Despite news on Nov. 9 that a COVID-19 vaccine is 90% effective, it is important to note that it still could be several more months until it's widely available, and there are some potential issues that come with it. "The challenges with this vaccine is it has to be stored at -94 degree," said Dr. Shad Marvasti, Director of Public Health at the University of Arizona College of Medicine. "Most vaccines are stored at 35°F to 45°F, in a standard refrigerator." KSAZ-TV (Fox) Phoenix Pharmather Inc. Licenses UArizona Parkinson’s Disease Treatment Nov. 10, 2020 Researchers at the University of Arizona College of Medicine – Tucson have developed a method of using ketamine in the treatment of Parkinson’s disease. The university has entered into an exclusive licensing agreement with Pharmather Inc., a subsidiary of Newscope Capital Corporation, for the development and commercialization of the method. BizTucson Arizona Doctor Cautiously Optimistic About Pfizer COVID-19 Vaccine Nov. 10, 2020 On Monday, pharmaceutical maker Pfizer reported it’s COVID-19 vaccine appears to be 90% effective. Dr. Shad Marvasti, with the University of Arizona College of Medicine Phoenix, is cautiously optimistic about the news. “We still want to look at the details to verify this, but it definitely sounds very promising and it’s good to hear,” Marvasti said. However, Marvasti cautions that adhering to mitigation efforts like wearing a mask and social distancing is critical even if the vaccine is approved. KJZZ-FM (NPR) Phoenix Expert Warns Coronavirus in Arizona Could Reach ‘Crisis Point’ After Thanksgiving Nov. 10, 2020 As coronavirus cases grow in Arizona, the state could reach a “crisis point” after Thanksgiving, one expert recently warned. “I don’t see us reaching any particular crisis point before Thanksgiving,” Dr. Joe Gerald, an associate professor with the University of Arizona’s Zuckerman College of Public Health, told the Arizona Daily Star. “But once we hit Thanksgiving and move towards Christmas and New Year’s, I think we will eventually reach a crisis point.” New York Post Local Doctors Hopeful After Promising Pfizer Vaccine News Nov. 10, 2020 A potential COVID-19 vaccine breakthrough after big pharma giant Pfizer said Monday its vaccine is 90 percent effective. "It's incredibly encouraging that the Pfizer vaccine worked," Connick, a professor at the University of Arizona College of Medicine, said. "I think it bodes well for all the vaccines that they may all be successful which will be successful." KVOA-TV (NBC) Tucson Pagination « First First page ‹ Previous Previous page … 284 285 286 287 288 289 290 291 292 … Next › Next page Last » Last page
Dr. Ali Baaj to Build UArizona-Banner Spine Program from Scratch in New Role Nov. 11, 2020 Spine surgeon Ali Baaj, MD, is the inaugural chief of spine surgery at the University of Arizona College of Medicine-Phoenix and Banner-University Medical Center Phoenix. As spine surgery chief, Dr. Baaj will build a new academic spine program at UArizona-Banner. Becker's Spine Review
The Swinging Pendulum of PSA Screening Nov. 11, 2020 The debate continues over the practice of mass screening of healthy men with prostate-specific antigen (PSA) blood tests for the early detection of prostate cancer. The article cites Richard Ablin, PhD, of the University of Arizona College of Medicine, who discovered PSA in 1970. He stressed that PSA testing was not intended for use for mass screening but rather to follow men with advanced disease. MedPage Today
COVID-19: Vaccines Continue to Progress as More Proof of Long-Lasting Immunity Emerges Nov. 11, 2020 Researchers at the University of Arizona College of Medicine in Tucson have found that people who have had COVID-19 develop long-lasting immunity. Their study appears in the journal Immunity. Medical News Today
Moderna’s Personalized Cancer Vaccine Shows Promise Nov. 11, 2020 A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer. PharmaLive
Pandemic Shines Light on Complex Coexistence of Modern Times, Traditional Ways on Navajo Nation Nov. 10, 2020 Traditional healers, who once played critical roles in governance and health care in the Navajo Nation, are dwindling in number and influence, experts and community leaders say, even as a deadly coronavirus assaults the tribe. Michelle Kahn-John, a professor of nursing at the University of Arizona and secretary of the Diné Hataalii Association, is quoted. This article was first published by the syndicated Cronkite News service on 11/10/20. Cronkite News
Arizona Medical Expert Says There Could Be Challenges in Distributing COVID-19 Vaccine Nov. 10, 2020 Despite news on Nov. 9 that a COVID-19 vaccine is 90% effective, it is important to note that it still could be several more months until it's widely available, and there are some potential issues that come with it. "The challenges with this vaccine is it has to be stored at -94 degree," said Dr. Shad Marvasti, Director of Public Health at the University of Arizona College of Medicine. "Most vaccines are stored at 35°F to 45°F, in a standard refrigerator." KSAZ-TV (Fox) Phoenix
Pharmather Inc. Licenses UArizona Parkinson’s Disease Treatment Nov. 10, 2020 Researchers at the University of Arizona College of Medicine – Tucson have developed a method of using ketamine in the treatment of Parkinson’s disease. The university has entered into an exclusive licensing agreement with Pharmather Inc., a subsidiary of Newscope Capital Corporation, for the development and commercialization of the method. BizTucson
Arizona Doctor Cautiously Optimistic About Pfizer COVID-19 Vaccine Nov. 10, 2020 On Monday, pharmaceutical maker Pfizer reported it’s COVID-19 vaccine appears to be 90% effective. Dr. Shad Marvasti, with the University of Arizona College of Medicine Phoenix, is cautiously optimistic about the news. “We still want to look at the details to verify this, but it definitely sounds very promising and it’s good to hear,” Marvasti said. However, Marvasti cautions that adhering to mitigation efforts like wearing a mask and social distancing is critical even if the vaccine is approved. KJZZ-FM (NPR) Phoenix
Expert Warns Coronavirus in Arizona Could Reach ‘Crisis Point’ After Thanksgiving Nov. 10, 2020 As coronavirus cases grow in Arizona, the state could reach a “crisis point” after Thanksgiving, one expert recently warned. “I don’t see us reaching any particular crisis point before Thanksgiving,” Dr. Joe Gerald, an associate professor with the University of Arizona’s Zuckerman College of Public Health, told the Arizona Daily Star. “But once we hit Thanksgiving and move towards Christmas and New Year’s, I think we will eventually reach a crisis point.” New York Post
Local Doctors Hopeful After Promising Pfizer Vaccine News Nov. 10, 2020 A potential COVID-19 vaccine breakthrough after big pharma giant Pfizer said Monday its vaccine is 90 percent effective. "It's incredibly encouraging that the Pfizer vaccine worked," Connick, a professor at the University of Arizona College of Medicine, said. "I think it bodes well for all the vaccines that they may all be successful which will be successful." KVOA-TV (NBC) Tucson